Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Kaplan-Meier curves showing the cumulative incidence of the primary end point at 30 days and at six months. The primary end point was a composite of death, reinfarction, recurrent unstable ischemia, or stroke after random assignment to treatment with tenecteplase (TNK) alone or TNK-facilitated angioplasty. In the TNK-facilitated angioplasty group, there was a 58% relative reduction in the risk of the primary end point at 30 days (log-rank p = 0.03) (top). At six months, there was a 53% reduction in the risk of the primary end point in the TNK-facilitated angioplasty group (log-rank p = 0.03) (bottom).
|
